U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 075469

Expand all

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE)
2.5MG;6.25MG
Marketing Status: Discontinued
Active Ingredient: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075469
Product Number: 001
Approval Date: Sep 25, 2000
Applicant Holder Full Name: WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE)
5MG;6.25MG
Marketing Status: Discontinued
Active Ingredient: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075469
Product Number: 002
Approval Date: Sep 25, 2000
Applicant Holder Full Name: WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE)
10MG;6.25MG
Marketing Status: Discontinued
Active Ingredient: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075469
Product Number: 003
Approval Date: Sep 25, 2000
Applicant Holder Full Name: WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top